Cargando…
Capitalizing glycomic changes for improved biomarker-based cancer diagnostics
Cancer serum biomarkers are valuable or even indispensable for cancer diagnostics and/or monitoring and, currently, many cancer serum markers are routinely used in the clinic. Most of those markers are glycoproteins, carrying cancer-specific glycan structures that can provide extra-information for c...
Autor principal: | Silva, Maria Luísa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344901/ https://www.ncbi.nlm.nih.gov/pubmed/37455827 http://dx.doi.org/10.37349/etat.2023.00140 |
Ejemplares similares
-
Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges
por: Wanyama, Francis Mugeni, et al.
Publicado: (2021) -
Novel diagnostic options for endometriosis – Based on the glycome and microbiome
por: Kovács, Zsuzsanna, et al.
Publicado: (2021) -
Towards an integrated proteomic and glycomic approach to finding cancer biomarkers
por: Taylor, Allen D, et al.
Publicado: (2009) -
Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer
por: Hanna-Sawires, Randa G., et al.
Publicado: (2021) -
Mass Spectrometry-Based N-Glycomics of Colorectal Cancer
por: Sethi, Manveen K., et al.
Publicado: (2015)